NCM
CALC icon

Nantahala Capital Management’s CalciMedica CALC Stock Holding History

Nantahala Capital Management’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,857
Closed -$3.18M – 114
2020
Q3 		$3.18M Buy
+17,857
New +$3.72M 0.1% 92

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nantahala Capital Management's CALC Position: Q4 2020 in Review

Nantahala Capital Management sold out of CalciMedica (CALC) in Q4 2020, closing a stake of 17,857 shares — an estimated $3.18M sold.

Nantahala Capital Management first reported a position in CALC in Q3 2020 and held it in 1 quarter. The position peaked at $3.18M in Q3 2020. 33 funds tracked by Wall St. Rank hold CALC as of Q4 2020.

  • Nantahala Capital Management reported no remaining CalciMedica position as of Q4 2020 after selling out during the quarter.
  • Nantahala Capital Management sold 17,857 CalciMedica shares in Q4 2020, an estimated $3.18M.
  • Nantahala Capital Management first reported a position in CalciMedica in Q3 2020 and held it in 1 quarter.
  • Nantahala Capital Management's CalciMedica position peaked at $3.18M in Q3 2020.
  • 33 funds tracked by Wall St. Rank held CalciMedica as of Q4 2020.

Based on Nantahala Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.